Literature DB >> 24121001

Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis.

Brandon C Varr1, Shirin Zarafshar2, Terra Coakley2, Michaela Liedtke3, Richard A Lafayette4, Sally Arai5, Stanley L Schrier3, Ronald M Witteles6.   

Abstract

Entities:  

Keywords:  AL; ATP; ATTR; Cardiac amyloidosis; EMD; ICD; Implantable cardioverter-defibrillator; LVEF; N-terminal pro–brain natriuretic peptide; NSVT; NT-proBNP; SCD; Sudden cardiac death; VF; VT; Ventricular tachycardia; antitachycardia pacing; electromechanical dissociation; implantable cardioverter-defibrillator; left ventricular ejection fraction; light-chain amyloidosis; nonsustained ventricular tachycardia; sudden cardiac death; transthyretin amyloidosis; ventricular fibrillation; ventricular tachycardia

Mesh：

Year:  2013        PMID： 24121001     DOI： 10.1016/j.hrthm.2013.10.026

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  20 in total

Review 1.  Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.

Authors:  Frederick L Ruberg; Martha Grogan; Mazen Hanna; Jeffery W Kelly; Mathew S Maurer
Journal:  J Am Coll Cardiol       Date:  2019-06-11       Impact factor: 24.094

Review 2.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

Review 3.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 4.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

5.  Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.

Authors:  Ketna S Patel; Philip N Hawkins; Carol J Whelan; Julian D Gillmore
Journal:  BMJ Case Rep       Date:  2014-12-22

Review 6.  Clinical management of amyloid cardiomyopathy.

Authors:  Morris M Kim; Clinton M Kolseth; Dayna Carlson; Ahmad Masri
Journal:  Heart Fail Rev       Date:  2021-09-01       Impact factor: 4.654

Review 7.  Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond.

Authors:  Biobelemoye Irabor; Jacqueline M McMillan; Nowell M Fine
Journal:  Front Cardiovasc Med       Date:  2022-05-17

Review 8.  Amyloid and the Heart.

Authors:  Aaron M Wolfson; Kevin S Shah; Jignesh K Patel
Journal:  Curr Cardiol Rep       Date:  2019-12-03       Impact factor: 2.931

Review 9.  Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis-A Narrative Literature Review.

Authors:  Aleksandra Liżewska-Springer; Grzegorz Sławiński; Ewa Lewicka
Journal:  J Clin Med       Date:  2021-04-25       Impact factor: 4.241

Review 10.  Infiltrative Cardiomyopathies.

Authors:  David Bejar; Paolo C Colombo; Farhana Latif; Melana Yuzefpolskaya
Journal:  Clin Med Insights Cardiol       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.